Key Takeaways
- Former KwaZulu‑Natal Health MEC Peggy Yoliswa Nkonyeni appeared in the Pietermaritzburg High Court on summons facing fraud and corruption charges tied to hospital procurement contracts allegedly worth over R100 million.
- The contracts concerned water purification units (Watakas) and self‑generating oxygen units (Oxyntakas) awarded to Intaka Holdings, a company owned by Uruguayan businessman Dr. Gaston Savoi.
- Prosecutors allege that Nkonyeni, co‑accused Lindelihle Mkhwanazi and Rowmoor Investments 738 (Pty) Ltd accepted two R500 000 payments from Intaka to improperly influence the procurement process.
- The matter was postponed to 11 June 2026 (Durban High Court) for legal representation confirmation, with a pre‑trial conference set for 23 July 2026.
- Savoi previously pleaded guilty in September 2024 to fraud and corruption, receiving a R5 million fine, a suspended 10‑year sentence, a confiscation order of R60 million and a R15 million cost contribution.
- The case highlights ongoing efforts to tackle corruption in provincial health procurement and underscores the legal consequences for both public officials and private contractors implicated in fraudulent schemes.
Background and Charges Against Peggy Yoliswa Nkonyeni
Peggy Yoliswa Nkonyeni, the former Member of the Executive Council (MEC) for Health in KwaZulu‑Natal, was served with a court summons and appeared in the Pietermaritzburg High Court on Thursday to answer allegations of fraud and corruption. The charges stem from her alleged involvement in the procurement of specialised medical equipment—water purification units known as Watakas and self‑generating oxygen units referred to as Oxyntakas—for hospitals across the province during her tenure. According to the National Prosecuting Authority (NPA), the purported value of the contracts exceeds R100 million, prompting the state to pursue criminal action. Nkonyeni, aged 64, is accused of abusing her official position to facilitate irregular tender processes that favoured a specific supplier, thereby compromising transparency and public trust in health‑service procurement.
Details of the Alleged Fraudulent Procurement Scheme
The state’s case centres on the awarding of contracts to Intaka Holdings, a firm owned by Uruguayan businessman Dr. Gaston Savoi. Prosecutors contend that the tender procedures for the Watakas and Oxyntakas were manipulated and misrepresented, allowing Intaka Holdings to secure undue financial benefit. Natasha Ramkisson‑Kara, regional spokesperson for the NPA, explained that the alleged scheme involved falsifying documentation, bypassing standard evaluation criteria, and ensuring that Intaka’s bids prevailed despite lacking competitive merit. The resulting contracts allegedly enabled Intaka to receive payments far above market rates, enriching the company by more than R100 million at the expense of the provincial health budget. This manipulation, prosecutors argue, constitutes both fraud—through deceitful misrepresentation—and corruption—through the illicit exchange of value for preferential treatment.
Roles of Co‑Accused and the Alleged Payments
Alongside Nkonyeni, the indictment lists several co‑accused: Lindelihle Mkhwanazi, Busisiwe Nyembezi, Victor Ntshangase, Alson Sipho Buthelezi, Sandile Kuboni, Kuboni Shezi Incorporated, and Rowmoor Investments 738 (Pty) Ltd. The NPA alleges that between August 2006 and November 2007, Nkonyeni, Mkhwanazi and Rowmoor Investments acted with a common purpose, agreeing to accept two payments of R500 000 each from Intaka Holdings. According to Ramkisson‑Kara, these payments were intended to improperly influence the promotion, execution, or procurement of the Wataka and Oxyntaka contracts. By allegedly receiving these illicit funds, the accused are said to have created a quid‑pro‑quo arrangement that compromised the integrity of the procurement process and facilitated the unlawful enrichment of Intaka Holdings.
Legal Proceedings and Postponement Details
Following the formal addition of Nkonyeni and Mkhwanazi to the list of accused on Thursday, the court postponed the matter to 11 June 2026, with the hearing to be held in the Durban High Court. The adjournment was granted to allow Mkhwanazi to secure legal representation and to provide both him and Nkonyeni with the state’s statements of case. All accused, including Nkonyeni and Mkhwanazi, are required to return to the Durban High Court on 23 July 2026 for a pre‑trial conference, where procedural matters such as plea negotiations, discovery timelines, and trial dates will be addressed. The postponement reflects the complexity of the case, the volume of documentary evidence, and the need to ensure that each defendant receives a fair opportunity to prepare their defence.
Connection to Gaston Savoi’s Prior Conviction
The prosecution’s case against Nkonyeni and her co‑accused is closely linked to the earlier conviction of Dr. Gaston Savoi, the Uruguayan businessman who owns Intaka Holdings. In September 2024, Savoi pleaded guilty in the Pietermaritzburg High Court to four counts of fraud and six counts of corruption committed in KwaZulu‑Natal and the Northern Cape between 2004 and 2007. His resolution came via a plea and sentence agreement under Section 105A of the Criminal Procedure Act, resulting in a R5 million fine, a 10‑year prison sentence (suspended for five years), an additional 10‑year custodial term, a confiscation order of R60 million in favour of the state, and a directive to contribute R15 million toward costs arising from curatorship proceedings linked to the Asset Forfeiture Unit restraint application. Savoi’s admission of guilt and the substantial financial penalties imposed on him provide a factual foundation for the allegations against the public officials who allegedly facilitated his company’s illicit gains.
Implications and Next Steps
The ongoing prosecution of Peggy Yoliswa Nkonyeni underscores a broader commitment by South African law‑enforcement agencies to combat corruption in provincial health procurement, a sector historically vulnerable to fraudulent practices. Should the court ultimately find Nkonyeni and her co‑accused guilty, the case could result in significant custodial sentences, financial penalties, and asset forfeiture, echoing the sanctions imposed on Savoi. Moreover, the outcome may deter future collusion between public officials and private contractors by demonstrating that manipulation of tender processes will be met with rigorous legal scrutiny. As the matter progresses toward the pre‑trial conference in July 2026 and the eventual trial in June 2026, stakeholders—including healthcare providers, taxpayers, and anti‑corruption watchdogs—will be watching closely to see how the judiciary addresses these serious allegations and what remedial measures emerge to safeguard public funds.